Final Push for Pandemic Treaty Amidst Deep Divisions on Data and Benefit Sharing

The global community stands at a critical juncture as delegates convene for a final, intensive week of negotiations at the World Health Organization (WHO) to hammer out a pandemic treaty. This landmark agreement, spurred by the stark lessons of the COVID-19 pandemic, aims to create a more coordinated and equitable global response to future health crises. However, the path forward is fraught with significant challenges, particularly concerning the equitable sharing of pathogen data and the resulting benefits, such as life-saving vaccines and treatments.

At the heart of the debate lies the Pandemic and Fair Benefit Sharing (PABS) system. Developing nations, particularly those in Africa, harbor deep-seated mistrust, fearing they will share vital pathogen samples without guaranteed access to the medical countermeasures developed from them. This echoes the inequities experienced during the COVID-19 vaccine rollout. Conversely, some developed nations and pharmaceutical industries question the economic viability and incentives for contributing without assured returns on investment. The complexities are further compounded by the need to integrate genetic data sharing, now as crucial as sharing physical virus samples for developing diagnostics, treatments, and vaccines.

“

developing countries expressed distrust because they were worried they would share viruses without guarantees of fair access to vaccines during a crisis.

While a historic agreement was reached in May 2025, the PABS element, arguably the most crucial, was deferred for later finalization. The current deadline looms, with nations striving to reach consensus before the World Health Assembly on May 18. Despite significant differences, diplomats like Brazil's Jean Karydakis express cautious optimism, acknowledging the slow progress and the difficulty of compromise, even as the European Union shows some flexibility. For nations like South Africa, the demand extends to technology transfer, while the poorest countries prioritize direct access to health products. The ongoing discussions on licensing, technology transfer, and health system capacity building remain central points of contention, highlighting the deep divisions that must be bridged to ensure a truly global and equitable pandemic preparedness framework.

“

the agreement is still possible even though there are big differences of opinion.